Novartis AG
METHOD OF DERIVING A VALUE FOR PERCENT BIOMARKER POSITIVITY FOR SELECTED CELLS PRESENT IN A FIELD OF VIEW

Abstract:

The invention relates, in part, to methods of deriving a value for % biomarker positivity (PBP) for all cells or optionally, one or more subsets thereof, present in a field of view of a tissue sample from a cancer patient. The values for PBP can be indicative of a patient's response to immunotherapy.